InnovaRx Innova Health Strategies

E09.3499

Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 3 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 9 never code together
E09code
Excludes1
  • diabetes mellitus due to underlying condition (E08.-)E08.-
  • gestational diabetes (O24.4-)O24.4-
  • neonatal diabetes mellitus (P70.2)P70.2
  • postpancreatectomy diabetes mellitus (E13.-)E13.-
  • postprocedural diabetes mellitus (E13.-)E13.-
  • secondary diabetes mellitus NEC (E13.-)E13.-
  • type 1 diabetes mellitus (E10.-)E10.-
  • type 2 diabetes mellitus (E11.-)E11.-
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

7th character 4
1 right eye
2 left eye
3 bilateral
9 unspecified eye this code
Instructional notes 8
E09code
Code first
  • poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)T36-T65
Use additional code
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)T36-T50
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)Z79.85
  • insulin (Z79.4)Z79.4
  • oral antidiabetic drugs (Z79.84)Z79.84
  • oral hypoglycemic drugs (Z79.84)Z79.84
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Official Guidelines 17 names this code

ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.

I.C.4.a Diabetes mellitus names this code p.39

The diabetes mellitus codes are combination codes that include the type of diabetes mellitus, the body system affected, and the complications affecting that body system. As many codes within a particular category as are necessary to describe all of the complications of the disease may be used. They should be sequenced based on the reason for a particular encounter. Assign as many codes from categories E08 – E13 as needed to identify all of the associated conditions that the patient has.

I.C.4.a.6 Secondary diabetes mellitus names this code p.41

Codes under categories E08, Diabetes mellitus due to underlying condition, E09, Drug or chemical induced diabetes mellitus, and E13, Other specified diabetes mellitus, identify complications/manifestations associated with secondary diabetes mellitus. Secondary diabetes is always caused by another condition or event (e.g., cystic fibrosis, malignant neoplasm of pancreas, pancreatectomy, adverse effect of drug, or poisoning).

I.C.4.a.6.b Assigning and sequencing secondary diabetes codes and its names this code p.42

causes The sequencing of the secondary diabetes codes in relationship to codes for the cause of the diabetes is based on the Tabular List instructions for categories E08, E09 and E13.

I.C.15.g Diabetes mellitus in pregnancy names this code p.66

Diabetes mellitus is a significant complicating factor in pregnancy. Pregnant patients who are diabetic should be assigned a code from category O24, Diabetes mellitus in pregnancy, childbirth, and the puerperium, first, followed by the appropriate diabetes code(s) (E08-E13) from Chapter 4.

I.C.4.a.1 Type of diabetes chapter guidance p.39

The age of a patient is not the sole determining factor, though most type 1 diabetics develop the condition before reaching puberty. For this reason, type 1 diabetes mellitus is also referred to as juvenile diabetes.

I.C.4.a.1.a Presymptomatic Type 1 Diabetes Mellitus chapter guidance p.39

Codes E10.A-, Type 1 diabetes mellitus, presymptomatic, are assigned for early-stage type 1 diabetes that predates the onset of symptoms.

I.C.4.a.1.b Type 2 diabetes mellitus in remission chapter guidance p.40

Code E11.A, Type 2 diabetes mellitus without complications in remission, is assigned based on provider documentation that the diabetes mellitus is in remission. If the documentation is unclear as to whether the Type 2 diabetes mellitus has achieved remission, the provider should be queried. For example, the term “resolved” is not synonymous with remission.

I.C.4.a.2 Type of diabetes mellitus not documented chapter guidance p.40

If the type of diabetes mellitus is not documented in the medical record the default is E11.-, Type 2 diabetes mellitus.

I.C.4.a.3 Diabetes mellitus and the use of insulin, oral hypoglycemics, and injectable non-insulin drugs chapter guidance p.40

If the documentation in a medical record does not indicate the type of diabetes but does indicate that the patient uses insulin, code E11-, Type 2 diabetes mellitus, should be assigned. Additional code(s) should be assigned from category Z79 to identify the long-term (current) use of insulin, oral hypoglycemic drugs, or injectable non-insulin antidiabetic, as follows: If the patient is treated with both oral hypoglycemic drugs and insulin, both code Z79.4, Long term (current) use of insulin, and code Z79.84, Long term (current) use of oral hypoglycemic drugs, should be assigned. If the patient is treated with both insulin and an injectable non-insulin antidiabetic drug, assign codes Z79.4, Long term (current) use of insulin, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. If the patient is treated with both oral hypoglycemic drugs and an injectable non-insulin antidiabetic drug, assign codes Z79.84, Long term (current) use of oral hypoglycemic drugs, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. Code Z79.4 should not be assigned if insulin is given temporarily to bring a type 2 patient’s blood sugar under control during an encounter.

I.C.4.a.4 Diabetes mellitus in pregnancy and gestational diabetes chapter guidance p.40

See Section I.C.15. Diabetes mellitus in pregnancy. See Section I.C.15. Gestational (pregnancy induced) diabetes

I.C.4.a.5.a Underdose of insulin due to insulin pump failure chapter guidance p.40

An underdose of insulin due to an insulin pump failure should be assigned to a code from subcategory T85.6, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, that specifies the type of pump malfunction, as the principal or first-listed code, followed by code T38.3X6-, Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs. Additional codes for the type of diabetes mellitus and any associated complications due to the underdosing should also be assigned.

I.C.4.a.5.b Overdose of insulin due to insulin pump failure chapter guidance p.41

The principal or first-listed code for an encounter due to an insulin pump malfunction resulting in an overdose of insulin, should also be T85.6-, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, followed by code T38.3X1-, Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional).

I.C.4.a.6.a Secondary diabetes mellitus and the use of insulin, oral chapter guidance p.41

hypoglycemic drugs, or injectable non-insulin drugs For patients with secondary diabetes mellitus who routinely use insulin, oral hypoglycemic drugs, or injectable non-insulin drugs, additional code(s) from category Z79 should be assigned to identify the long-term (current) use of insulin, oral hypoglycemic drugs, or non-injectable non-insulin drugs as follows: If the patient is treated with both oral hypoglycemic drugs and insulin, both code Z79.4, Long term (current) use of insulin, and code Z79.84, Long term (current) use of oral hypoglycemic drugs, should be assigned. If the patient is treated with both insulin and an injectable non- insulin antidiabetic drug, assign codes Z79.4, Long- term (current) use of insulin, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. If the patient is treated with both oral hypoglycemic drugs and an injectable non-insulin antidiabetic drug, assign codes Z79.84, Long-term (current) use of oral hypoglycemic drugs, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. Code Z79.4 should not be assigned if insulin is given temporarily to bring a secondary diabetic patient’s blood sugar under control during an encounter.

I.C.4.a.6.b.i Secondary diabetes mellitus due to pancreatectomy chapter guidance p.42

For postpancreatectomy diabetes mellitus (lack of insulin due to the surgical removal of all or part of the pancreas), assign code E89.1, Postprocedural hypoinsulinemia. Assign a code from category E13 as the principal or first- listed diagnosis and a code from subcategory Z90.41, Acquired absence of pancreas, as an additional code.

I.C.4.a.6.b.ii Secondary diabetes due to drugs chapter guidance p.42

Secondary diabetes may be caused by an adverse effect of correctly administered medications, poisoning or sequela of poisoning. See section I.C.19.e. for coding of adverse effects and poisoning, and section I.C.20 for external cause code reporting.

I.C.4.b Obesity chapter guidance p.42

The obesity codes in category E66, Overweight and obesity, include codes related to the cause of obesity, such as drug-induced obesity (E66.1), and codes related to effects of obesity, such as code E66.2, Morbid (severe) obesity with alveolar hypoventilation. There are other codes related to obesity in other categories of the classification, such as E88.82, Obesity due to disruption of MC4R pathway; and codes in fifth character subcategory O99.21, Obesity complicating pregnancy, childbirth, and the puerperium.

I.C.4.b.1 Obesity class chapter guidance p.42

The obesity class codes in subcategory E66.81, Obesity class, require a fifth character to convey the severity of obesity. The obesity class should be documented in the medical record by the provider for these codes to be assigned. The obesity class codes can be reported with other obesity codes in the classification found in Chapters 4 and 15 to fully describe the condition. However, if both class 3 obesity and morbid obesity are documented, only a code for class 3 obesity should be assigned as it is more specific.

Index entries leading here 1
  • Aneurysm (anastomotic) (artery) (cirsoid) (diffuse) (false) (fusiform) (multiple) (saccular) I72.9
    • retina — see also Disorder, retina, microaneurysms
      • diabetic — see E08-E13 with .3-
Alongside this code 3 same parent — E09.349
Medications 5

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC18 ESRD21HCC18 ESRD24HCC18 RX08HCC30

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
E09.349
Block
E08-E13
Siblings
3

Present FY2024–FY2027.